These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32598787)

  • 1. [Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity].
    Ovsyannikov ES; Avdeev SN; Budnevsky AV
    Ter Arkh; 2020 Apr; 92(3):13-18. PubMed ID: 32598787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients.
    Savchenko L; Mykytiuk M; Cinato M; Tronchere H; Kunduzova O; Kaidashev I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2569-2575. PubMed ID: 30197513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
    Poulain M; Doucet M; Drapeau V; Fournier G; Tremblay A; Poirier P; Maltais F
    Chron Respir Dis; 2008; 5(1):35-41. PubMed ID: 18303100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
    Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
    Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
    Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
    Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P; Petrasova D; Stancak B; Tkacova R
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
    Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
    Lung; 2008; 186(6):403-9. PubMed ID: 18807087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between hyperinflation defined as an elevated RV/TLC ratio and body composition and cytokine profile in patients with chronic obstructive pulmonary disease.
    Rubinsztajn R; Przybyłowski T; Maskey-Warzęchowska M; Paplińska-Goryca M; Karwat K; Nejman-Gryz P; Chazan R
    Pneumonol Alergol Pol; 2015; 83(2):120-5. PubMed ID: 25754053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of inflammatory biomarkers in COPD and asthma exacerbations.
    Vassiliou AG; Vitsas V; Kardara M; Keskinidou C; Michalopoulou P; Rovina N; Dimopoulou I; Orfanos SE; Tsoukalas G; Koutsoukou A; Kotanidou A
    Adv Respir Med; 2020; 88(6):558-566. PubMed ID: 33393648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could Disease Severity and Inflammatory Markers (IL-6, Hs-CRP, TNF-α) be Related to Frailty in COPD? A Prospective Study.
    R S; M N; L D; N K; G S; Kk B
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise alleviates depression related systemic inflammation in chronic obstructive pulmonary disease patients.
    Abd El-Kader SM; Al-Jiffri OH
    Afr Health Sci; 2016 Dec; 16(4):1078-1088. PubMed ID: 28479901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function.
    Lin X; Fan Y; Wang X; Chi M; Li X; Zhang X; Sun D
    Am J Med Sci; 2017 Oct; 354(4):388-394. PubMed ID: 29078843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
    Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
    Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
    Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.